Zenapax
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Newly Diagnosed With Type 1 Diabetes
Conditions
Newly Diagnosed With Type 1 Diabetes
Trial Timeline
Jul 1, 2000 → Feb 23, 2007
NCT ID
NCT00198146About Zenapax
Zenapax is a phase 2 stage product being developed by Roche for Newly Diagnosed With Type 1 Diabetes. The current trial status is completed. This product is registered under clinical trial identifier NCT00198146. Target conditions include Newly Diagnosed With Type 1 Diabetes.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00198146 | Phase 2 | Completed |
Competing Products
18 competing products in Newly Diagnosed With Type 1 Diabetes